EHRA Congress 2018: BIOTRONIK Debuts Cardiac Device Expert App; Satellite Symposium Highlights CASTLE-AF

BIOTRONIK unveiled its first-ever digital education app today, just ahead of the company’s appearance at the 2018 European Heart Rhythm Association (EHRA) Congress in Barcelona.

The Cardiac Device Expert App is available on iOS and Android platforms, and works on smartphone and tablet devices. BIOTRONIK customers can practice questions from 80 uploaded real-life cases, representing differing levels of difficulty. Additional tools, such as ECG and fluoroscopy, support users in finding solutions. BIOTRONIK will premiere a lite version of the app at EHRA 2018.

“This app launch represents our commitment to digital education,” said Dr. Alexander Uhl, Senior Vice President of Corporate Marketing at BIOTRONIK. “We are proud of our track record in providing excellent face-to-face education and training. Now app users can benefit from that expertise and learning tools anytime, anywhere.”

Alongside the Cardiac Device Expert App’s first showcase, the BIOTRONIK-supported CASTLE-AF study, recently published in the New England Journal of Medicine1 will feature prominently at a satellite symposium on Monday, March 19. Exploring the theme “Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation – Quo Vadis?” the symposium will also address how remote monitoring technology can improve clinical outcomes for this patient group.

The EHRA 2018 Congress runs from March 18-20, 2018 at the Fira Gran Via in Barcelona. Visit BIOTRONIK at booth B300. BIOTRONIK’s satellite symposium takes place on March 19 from 12:45-1:45 p.m. in the venue’s Room Furman.


1Marrouche NF et al. N Engl J Med. 2018, 378.



BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.